Close Menu

NEW YORK (360Dx) – Bruker said after the close of markets on Friday that the US Food and Drug Administration had cleared use of the company's MALDI Biotyper system for the detection of Candida auris.

According to Bruker, the MALDI Biotyper is now cleared by FDA for the clinical identification of 333 species or species groups covering 424 bacteria and yeast species.

A yeast, C. auris is a cause of infections in settings like hospitals and can be resistant to antifungal drugs typically used to treat Candida infections.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.